JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2015, Vol. 29 ›› Issue (1): 44-48.doi: 10.6040/j.issn.1673-3770.0.2014.272

Previous Articles     Next Articles

Allograft rejection after high risk corneal transplantation with Foxp3 Gene-transferred effective T cells

ZHAO Jun1 2, LIU Jing1, WANG Da-jiang3, CHEN Guo-ling1, WANG Qi2, ZHANG Han1   

  1. 1. Liaohe Oilfield General Hospital, Panjin 124010, Liaoning, China;
    2. The Second Hospital of Shandong University, Jinan 250033, Shandong, China;
    3. Chinese PLA General Hospital, Beijing 100853, China
  • Received:2014-08-17 Online:2015-02-16 Published:2015-02-16

PDF (PC)

348

Abstract: Objective To observe the effects of Foxp3 gene-transfected Teff lymphocytes against the high-risk corneal transplantation rejection. Methods The Foxp3 gene-transfected Teff lymphocytes and the Teff lymphocytes were cultured together to observe the inhibitory effects on the Teff lymphocytes. Corneal neovascularization was induced by corneal suture in Balb/c mice and after one week, penetrating corneal transplantations were performed while Balb/c mice as receptors and C57/BL6 mice as donors. One day before the surgery, injection of Foxp 3 gene-transfected Teff lymphocytes were performed via tail vein of Balb/c mice. After the surgery, the state of corneal transplantation was monitored on a day to day basis and tail vein blood was sampled once every two weeks to check the lymphocyte types. Results The in vitro experiments showed strong inhibitory effects of Foxp3 gene-transfected Teff lymphocytes on the Teff lymphocytes. To the high-risk corneal transplantation mice, the Foxp3 gene-transfected Teff lymphocytes could moderately extend the survival time of the grafts (19.71±4.19d) while the survival time of the corneal grafts in the Treg group was 19.28±4.46d (P>0.05). On the contrary, the comparison between the Foxp3 gene-transfected Teff lymphocytes and the blank group (15.57± 2.22d) demonstrated some significance (P<0.05). Flow cytology indicated that the Foxp3 gene-transfected lymphocytes could delay the proliferation of CD4+T and CD8+T lymphocytes.Conclusion The Foxp3 gene-transfected Teff lymphocytes could prevent transplant rejection.

Key words: Teff, Treg, High risk, Foxp3 gene, Penetrate cornea transplant, Allograft rejection

CLC Number: 

  • R779.6
[1] Sonoda Y, Streilein, J W.Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts[J]. J Immunol, 1993, 150(5):1727-1734.
[2] Francis J, Till S, Durham S R. Induction of IL-10+CD4+CD25+ T cells by grass pollen immunotherapy[J]. J Allergy Clin Immunol, 2003, 111(6):1255-1261.
[3] Cao D, Malmstrom V, Baecher-Allan C, et al. Isolation and functional characterization of regulatory CD25 bright CD4+ T cells from the target organ of patientswith rheumatoid arthritis[J]. Eur J Immunol, 2003, 33(1):213-215.
[4] Gershon RK, Kondo K. Infectious immunological tolerance[J]. Immunology, 1971, 21(6):903-914.
[5] Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3[J]. Science, 2003, 299(5609):1057-1061.
[6] Fontenot J D, Gavin M A, Rudensky A Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells[J]. NatImmunol, 2003, 4(4):330-336.
[7] Khattri R, Cox T, Yasayko S A, et al. An essential role for Scurfin in CD4+CD25+ T regulatory cells[J]. Nat Immunol, 2003, 4(4):337-342.
[8] Karube K, Ohshima K, Tsuchiya T, et al. Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia/lymphoma cells[J]. Br J Haematol, 2004, 126(1):81-84.
[9] Muthukumar T, Dadhania D, Ding R. Messenger RNA for FoxP3 in the Urine of Renal-Allograft Recipients[J]. N Engl J Med, 2005, 353(22):2342-2351.
[10] Karagiannidis C, Akdis M, Holopainen P, et al. Glucocorticoids upregulate FoxP3 expression and regulatory T cells in asthma[J]. J Allergy Clin Immunol, 2004, 114(6):1425-1433.
[11] Han G, Li Y, Wang J, et al. Active tolerance induction and prevention of autoimmune diabetes by immunogene therapy using recombinant adenoassociated virus expressing glutamic acid decarboxylase 65 peptide GAD(500-585)[J]. J Immunol, 2005, 174(8):4516-4524.
[12] Fontenot J D, Gavin M A, Rudensky A Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells[J]. Nat Immunol, 2003, 4(4):330-336.
[13] Walker M R, Kasprowicz D J, Gersuk V H, et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells[J]. J Clin Invest, 2003, 112(9):1437-1443.
[14] Apostolou I, von Boehmer H. In vivo instruction of suppressor commitment in naive T cells[J]. J Exp Med, 2004, 199(10):1401-1408.
[15] Curotto de Lafaille M A, Lino A C, Kutchukhidze N, et al. CD25-T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion[J]. J Immunol, 2004, 173(12):7259-7268.
[16] Cobbold S P, Castejon R, Adams E, et al. Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants[J]. J Immunol,2004, 172(10):6003-6010.
[17] Mucida D, Kutchukhidze N, Erazo A, et al. Oraltolerance in the absence of naturally occurring Tregs[J]. J Clin Investig, 2005, 115(7):1923-1933.
[18] Kretschmer K, Apostolou I, Hawiger D, et al. Inducing and expanding regulatory T cell populations by foreign antigen[J]. Nat Immunol, 2005, 6(12):1219-1227.
[19] Finney C A, Taylor M D, Wilson M S, et al. Expansion and activation of CD4+CD25+ regulatory T cells in Heligmosomoides polygyrus infection[J]. Eur J Immunol, 2007, 37(7):1874-1886.
[20] Curotto de Lafaille M A, Kutchukhidze N, Shen S, et al. Adap- tive Foxp3+ regulatory T cell-dependent and-independent control of allergic inflammation[J]. Immunity, 2008, 29(1):114-126.
[21] Taams L S, Akbar A N. Peripheral generation and function of CD4+CD25+ regulatory T cells[J]. Curr Top Microbiol Immunol, 2005, 293:115-131.
[22] Curotto de Lafaille M A, Lafaille J J. Natural and adaptive Foxp3+ regulatory T cells: more of the same or a division of labor?[J]. Immunity, 2009, 30(5):626-635.
[23] Viguier M, Lemaître F, Verola O, et al. Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells[J]. J Immunol, 2004, 173(2):1444-1453.
[1] ZHU Hui-tao, CAI Xiao-lan, FENG Xin, QI Jun-jun, ZHANG Jin-ling, MA Yue, LI Xue-zhong. Expression of TSLP and its relationship with the infiltrsting regulatory T cells in chronic rhinosinusitis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(2): 48-51.
[2] LIU Fang1, LAI Jian-xin1, LI Rui-yu1, LI Guan-zhen2. Th17/Treg cell ratio in the peripheral circμlation of human laryngeal squamous cell carcinoma. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(5): 4-7.
[3] Guojun Li1,2, MD, PhD, Xinliang Pan3, MD, PhD, Dapeng Lei3, MD, PhD et al. Sexual behavior and HPV infection in squamous cell carcinoma of the oropharynx [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(1): 1-7.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd